Clinical trials
Phase 2 Diabetes Mellitus trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
495 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 5 |
| 2001 | 10 |
| 2002 | 9 |
| 2003 | 16 |
| 2004 | 9 |
| 2005 | 13 |
| 2006 | 26 |
| 2007 | 31 |
| 2008 | 40 |
| 2009 | 25 |
| 2010 | 33 |
| 2011 | 23 |
| 2012 | 26 |
| 2013 | 25 |
| 2014 | 23 |
| 2015 | 23 |
| 2016 | 15 |
| 2017 | 18 |
| 2018 | 17 |
| 2019 | 13 |
| 2020 | 15 |
| 2021 | 15 |
| 2022 | 12 |
| 2023 | 11 |
| 2024 | 8 |
| 2025 | 12 |
| 2026 | 11 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 338 |
| Terminated | 54 |
| Unknown status | 38 |
| Withdrawn | 20 |
| Recruiting | 20 |
| Not yet recruiting | 12 |
| Active, not recruiting | 8 |
| Suspended | 3 |
| Enrolling by invitation | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 26 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 20 |
| AstraZeneca | 13 |
| Takeda | 11 |
| GlaxoSmithKline | 9 |
| Eli Lilly and Company | 7 |
| Massachusetts General Hospital | 6 |
| Ain Shams University | 5 |
| Novartis Pharmaceuticals | 5 |
| Pfizer | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus | 495 |
| Diabetes Mellitus, Type 2 | 148 |
| Diabetes Mellitus, Type 1 | 62 |
| Insulin Resistance | 45 |
| Obesity | 41 |
| Glucose Metabolism Disorders | 29 |
| Diabetic Neuropathies | 24 |
| Diabetic Retinopathy | 22 |
| Hypertension | 22 |
| Metabolic Diseases | 21 |
Trials
Showing 1 to 25 of 495. Each trial links to its page on Pharma Observatory.
395 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.